Eupraxia Pharmaceuticals, Inc. (EPRX) - Bozor qiymatining balans qiymatiga nisbati
Eupraxia Pharmaceuticals (EPRX) robotlashtirilgan liniyalarni ekspert klinik jarayonlar boshqaruvi bilan birlashtirish orqali uzoq muddatli ta'sir qiluvchi agentlar ishlab chiqarishni avtomatlashtiradi. Startap hozirda o'zining depot dori platformasini bozorga kiritishga tayyorlamoqda, sinovlarni yakunlamoqda va distributorlarni tanlamoqda. Ko'rsatkich 4.82 darajasida turibdi. Tarixiy narxlar dinamikasi prolongatsiya texnologiyalarining salohiyatini namoyish etadi, ular isbotlangan molekulalarni barqaror daromad manbalariga aylantiradi.
Eupraxia Pharmaceuticals (EPRX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Eupraxia Pharmaceuticals|EPRX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati eupraxiapharma.com|EPRX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Eupraxia Pharma|EPRX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Eupraxia Pharmaceuticals|Tezkor likvidlik eupraxiapharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Eupraxia Pharmaceuticals, Inc. - EPRX
Eupraxia Pharmaceuticals o'zining DiffuCORE texnologiyasi orqali reabilitatsiyani transformatsiya qilmoqda va Librexia uchun uzoq muddatli og'riq qoldiruvchi effektni ta'minlamoqda. Narxning buxgalteriya qiymatiga nisbati aktivlardan yuqori bo'lgan investitsiya premiyasi hajmini belgilaydi va kompaniyaning intellektual mulkiga bo'lgan bozor ishonchini aks ettiradi, bu esa tarixiy narx-buxgalteriya nisbati tendentsiyasi orqali korreksiya xavfini baholash imkonini beradi.
Raqobatchilar tahlili
HLN (Haleon plc) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati KVUE|Bozor qiymatining balans qiymatiga nisbati Verona Pharma|Jyong Biotech Limited - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati LGND|AMRX (Amneal Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|Bozor kapitallashuvining balans qiymatiga nisbati alvotech.com ALVO|LQDA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GLPG (Galapagos N.V.)|ANI Pharma (ANIP) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Afrezza|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com|Kapitallashuvning sof aktivlarga nisbati SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TECX: Kapitallashuvning sof aktivlarga nisbati|tonixpharma.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|SXTC: Bozor kapitallashuvining balans qiymatiga nisbati|BioHarvest Sciences, Inc. - Balans qiymatiga nisbatan bozor qiymati|EXOZ (Invizyne Technologies, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Oramed Pharma ORMP|Bozor qiymatining balans qiymatiga nisbati Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Cumberland Pharmaceuticals Inc (CPIX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|QNTM: Kapitallashuvning sof aktivlarga nisbati|FGEN - Bozor kapitallashuvining balans qiymatiga nisbati|Telomir Pharmaceuticals (TELO) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi RANI (Rani Therapeutics Holdings, Inc.)|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corp.|RLYB: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Pheton Holdings - Kapitallashuvning sof aktivlarga nisbati|APM: Kapitallashuvning balans qiymatiga nisbati|Lyra Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi impactbiomedinc.com IBO|TNFA: Bozor kapitallashuvining balans qiymatiga nisbati|cbdMD (YCBD) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati PRFX|CYTO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Lipella Pharmaceuticals, Inc. (LIPO)|OPTN: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PIRS (Pieris)|Balans qiymatiga nisbatan bozor qiymati PROC|Petros Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|QLI - Bozor kapitallashuvining balans qiymatiga nisbati|ACELYRIN (SLRN) - Bozor qiymatining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. - Balans qiymatiga nisbatan bozor qiymati